ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Why This Heart Drug Could Be a $5B Blockbuster for Novartis
January 25, 2018ZURICH (Reuters) - A Novartis executive said the Swiss company’s heart failure medicine Entresto could be used more widely in future, potentially making it a blockbuster drug with revenue potential of $4 billion to $5 billion a year. -
Array Biopharma Spun Off Heart Drug R&D Into New Subsidiary Yarra Therapeutics
December 28, 2017Array BioPharma has spun out some of its intellectual property and equipment into a new company, Yarra Therapeutics. Note that Yarra is Array spelled backwards. -
Common heart drug repurposed to treat rare cancer in Europe
January 18, 2017A drug that's commonly used to treat high blood pressure is being repurposed for a rare tissue cancer in Europe.
Pharma Sources Insight January 2025
